Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Brexpiprazole
Other

Brexpiprazole

Tracked across 1 events · 7 articles · First seen Jul 20, 2026 · Last active Aug 19, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Business
Lundbeck H1 2026 revenue growth
Lundbeck reported strong financial results for the first half of 2026, with total revenue growing 16% CER to DKK 13,588 million, driven by strong performance of Eptinezumab and Brexpiprazole. Adjusted EBITDA rose 19% CER to…
Impact: Major revenue contributor with 17% CER growth, supporting Lundbeck's commercial momentum.
Jul 20, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Brexpiprazole live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.